8622 — Huakang Biomedical Holdings Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$51.05m
- HK$17.91m
- CNY24.63m
Annual balance sheet for Huakang Biomedical Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 48.8 | 41.9 | 36.2 | 33.3 | 32.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10.7 | 10.3 | 11.7 | 15.5 | 17.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 63.5 | 59 | 53.7 | 53.4 | 53.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.3 | 10.8 | 10.4 | 8.27 | 9.74 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 78.7 | 72.7 | 67.1 | 66.4 | 65.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.21 | 9.27 | 8.64 | 9.78 | 13.1 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.03 | 10.8 | 9.36 | 9.88 | 14.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 70.7 | 61.9 | 57.7 | 56.5 | 51 |
| Total Liabilities & Shareholders' Equity | 78.7 | 72.7 | 67.1 | 66.4 | 65.3 |
| Total Common Shares Outstanding |